Journey Common Stock Shares Outstanding vs Short Term Debt Analysis
DERM Stock | USD 5.18 0.26 4.78% |
Journey Medical financial indicator trend analysis is infinitely more than just investigating Journey Medical Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Journey Medical Corp is a good investment. Please check the relationship between Journey Medical Common Stock Shares Outstanding and its Short Term Debt accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Common Stock Shares Outstanding vs Short Term Debt
Common Stock Shares Outstanding vs Short Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Journey Medical Corp Common Stock Shares Outstanding account and Short Term Debt. At this time, the significance of the direction appears to have weak relationship.
The correlation between Journey Medical's Common Stock Shares Outstanding and Short Term Debt is 0.35. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Journey Medical Corp, assuming nothing else is changed. The correlation between historical values of Journey Medical's Common Stock Shares Outstanding and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Journey Medical Corp are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Common Stock Shares Outstanding i.e., Journey Medical's Common Stock Shares Outstanding and Short Term Debt go up and down completely randomly.
Correlation Coefficient | 0.35 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Short Term Debt
Most indicators from Journey Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Journey Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Journey Medical's Selling General Administrative is very stable compared to the past year. As of the 11th of December 2024, Sales General And Administrative To Revenue is likely to grow to 3.97, while Tax Provision is likely to drop about 102.6 K.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 7.0M | 2.0M | 1.7M | 1.6M | Depreciation And Amortization | 2.6M | 4.4M | 3.9M | 4.0M |
Journey Medical fundamental ratios Correlations
Click cells to compare fundamentals
Journey Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Journey Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 33.9M | 51.9M | 97.3M | 105.2M | 76.8M | 73.0M | |
Short Long Term Debt Total | 5.3M | 5.4M | 910K | 23.0M | 17.7M | 16.8M | |
Other Current Liab | 18.8M | 26.0M | 23.4M | 26.8M | 20.6M | 25.8M | |
Total Current Liabilities | 20.9M | 28.1M | 51.6M | 66.8M | 41.9M | 46.9M | |
Total Stockholder Equity | 2.8M | 10.3M | 42.0M | 17.0M | 20.4M | 19.3M | |
Property Plant And Equipment Net | 1.2M | 89K | 175K | 189K | 101K | 96.0K | |
Net Debt | 502K | (2.8M) | (48.2M) | (9.0M) | (9.7M) | (10.2M) | |
Retained Earnings | (163K) | 5.1M | (38.9M) | (68.5M) | (72.4M) | (76.0M) | |
Accounts Payable | 2.0M | 2.0M | 22.8M | 37.0M | 18.1M | 15.5M | |
Cash | 4.8M | 8.2M | 49.1M | 32.0M | 27.4M | 26.1M | |
Non Current Assets Total | 8.6M | 16.7M | 12.8M | 27.5M | 20.4M | 16.4M | |
Non Currrent Assets Other | 656K | 3.0M | 6K | 150K | 95K | 5.7K | |
Cash And Short Term Investments | 4.8M | 8.2M | 49.1M | 32.0M | 27.4M | 26.1M | |
Net Receivables | 19.0M | 23.9M | 23.1M | 28.2M | 15.2M | 17.6M | |
Liabilities And Stockholders Equity | 33.9M | 51.9M | 97.3M | 105.2M | 76.8M | 73.0M | |
Non Current Liabilities Total | 10.2M | 13.6M | 3.6M | 21.3M | 14.6M | 13.9M | |
Other Current Assets | 655K | 1.7M | 4.9M | 3.3M | 3.6M | 3.4M | |
Other Stockholder Equity | 2.9M | 5.2M | 80.9M | 85.5M | 92.7M | 88.1M | |
Total Liab | 31.1M | 41.6M | 55.2M | 88.2M | 56.5M | 93.1M | |
Total Current Assets | 25.3M | 35.2M | 84.5M | 77.7M | 56.5M | 53.6M | |
Intangible Assets | 7.4M | 15.0M | 12.6M | 27.2M | 20.3M | 21.3M | |
Inventory | 857K | 1.4M | 9.9M | 14.2M | 10.2M | 8.2M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 2.921 | Quarterly Revenue Growth (0.58) | Return On Assets (0.17) | Return On Equity (1.30) |
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.